Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sclepat
- Development stage
- Unknown
- Lead developer
- SCLERA Healthcare
- Administration
- Ophthalmic
01
Overview
**Sclepat** is a Sclera ophthalmic-division commercial product listed by Sclera Healthcare. Publicly available product-page information confirms the product name and ophthalmic portfolio placement, but does not disclose its active ingredient, concentration, dosage form, therapeutic indication, or mechanism of action. Sclepat should not be conflated with the separately listed product **Sclepat-KT**, which is an olopatadine hydrochloride plus ketorolac ophthalmic combination. ([sclerahealthcare.com](https://sclerahealthcare.com/product/sclepat.html))
- Brand names
- Sclepat
Beyond the preview
Go deeper on Sclepat.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sclepat.